Searched for
INDIA PHARMA INDUSTRY
India, Uzbekistan could explore FTA, says Piyush Goyal; Uzbekistan invites Indian investment in mining, rare earthsIndia and Uzbekistan aim to double bilateral trade to three billion dollars within three years. Businesses are urged to increase investment...- India's exports from SEZs up 11.8% in 2025-26: GovtExports from special economic zones experienced a remarkable boost in 2025-26, eclipsing USD 185 billion. The pharmaceutical industry also ...
- India extends anti-dumping duty on select chemicals, metal goods; imposes on oneIndia has extended anti-dumping duties on four products, including chemicals and steel goods. New duties were imposed on metallurgical coke...
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
- Dividend alert! Last day to buy Vedanta Aluminium, Hyundai Motor among 25 stocks for dividend payout worth Rs 430As per Sebi's T+1 settlement cycle, investors must buy a company's shares at least one trading day before the record date to ensure the sha...
- Ahead of Market: 10 things that will decide stock market action on MondayThe Indian stock market rallied around 3% over the last week, recouping its early losses despite global volatility. Analysts expect the mar...
- Q1 earnings this week: SBI, Trent, Nykaa among 573 companies set to announce June quarter resultsThis week, 573 companies will announce their June quarter results, featuring prominent firms. Bharti Airtel and Nykaa are among those repor...
- Dividends & stock splits: Maruti Suzuki, ICICI Bank among nearly 100 stocks turning ex-date this week. Do you own?Nearly 100 stocks, including Maruti Suzuki, ICICI Bank, Coforge and Vedanta Aluminium, will trade ex-date between August 3 and August 7 for...
- Maharashtra-based SME stock plunges 20% as MD gets shot, director taken in police custodyIn an exchange filing, GSM Foils said the firing incident took place in the Naikpada area in Vasai-Virar, located near Mumbai. After gettin...
- Stocks in news: Maruti Suzuki, ITC, Vedanta, Swiggy, RILIndian markets traded in a narrow range, settling marginally higher with mixed cues. Maruti Suzuki, ITC, and Vedanta shares are in focus du...
- ET Family Business Awards: Serum Institute, Mankind, Varun Beverages among winners in the limelightSeveral Indian family businesses received awards for their significant contributions. Serum Institute of India was honored for philanthropi...
- Rs 104 lakh crore club: India's richest 3,040 now hold wealth equal to 30% of GDPIndia’s 3,040 richest individuals hold Rs 104 lakh crore in wealth, nearly 30% of nominal GDP, highlighting growing wealth concentration. T...
- How AI is helping pharma prevent drug recalls, counter fakes and improve patient safetyArtificial intelligence is revolutionizing the pharmaceutical sector by significantly reducing the instances of drug recalls. By improving ...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Bonus issues & dividends: Wipro, UltraTech Cement among more than 110 stocks turning ex-date this week. Do you own?Over 110 companies, including Wipro, UltraTech Cement and Britannia, will turn ex-date this week for dividends and bonus issues. Investors ...
- Pharma deal activity hits four-quarter low, but mega Sun Pharma acquisition drives valueIndia's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...
- Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says reshoring not practicalUS President Trump's proposed tariffs on imported generic drugs will not immediately affect Indian drugmakers. Indian companies export sign...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
Load More
